- Home
- NXGL vs XAIR Comparison
NXGL vs XAIR Comparison
Compare NXGL & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- XAIR
- Stock Information
- Founded
- NXGL 1997
- XAIR 2011
- Country
- NXGL United States
- XAIR United States
- Employees
- NXGL N/A
- XAIR N/A
- Industry
- NXGL Medical/Dental Instruments
- XAIR Medical/Dental Instruments
- Sector
- NXGL Health Care
- XAIR Health Care
- Exchange
- NXGL Nasdaq
- XAIR Nasdaq
- Market Cap
- NXGL 19.7M
- XAIR 17.0M
- IPO Year
- NXGL 2021
- XAIR N/A
- Fundamental
- Price
- NXGL $2.36
- XAIR $3.20
- Analyst Decision
- NXGL
- XAIR Strong Buy
- Analyst Count
- NXGL 0
- XAIR 3
- Target Price
- NXGL N/A
- XAIR $23.67
- AVG Volume (30 Days)
- NXGL 35.9K
- XAIR 378.7K
- Earning Date
- NXGL 08-13-2025
- XAIR 08-12-2025
- Dividend Yield
- NXGL N/A
- XAIR N/A
- EPS Growth
- NXGL N/A
- XAIR N/A
- EPS
- NXGL N/A
- XAIR N/A
- Revenue
- NXGL $10,228,000.00
- XAIR $3,705,000.00
- Revenue This Year
- NXGL $52.35
- XAIR $266.61
- Revenue Next Year
- NXGL $42.38
- XAIR $140.76
- P/E Ratio
- NXGL N/A
- XAIR N/A
- Revenue Growth
- NXGL 116.01
- XAIR 219.67
- 52 Week Low
- NXGL $2.10
- XAIR $2.90
- 52 Week High
- NXGL $5.10
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- NXGL 42.79
- XAIR 42.94
- Support Level
- NXGL $2.26
- XAIR $3.25
- Resistance Level
- NXGL $2.58
- XAIR $3.78
- Average True Range (ATR)
- NXGL 0.17
- XAIR 0.37
- MACD
- NXGL -0.03
- XAIR -0.01
- Stochastic Oscillator
- NXGL 18.25
- XAIR 21.43
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.